Gut health in children in Durham, North Carolina

Dr. Gillian Noel is a pediatric gastroenterologist and transplant specialist located at 4709 Creekstone Drive in Durham, North Carolina. Specializing in liver diseases, Dr. Noel cares for children of all ages with conditions such as autoimmune liver disease, biliary atresia, and progressive familial intrahepatic cholestasis. She also works with children before and after organ transplants, partnering with families to achieve the best outcomes. Dr. Noel aims to provide information and guidance to families facing the challenges of chronic liver disease, forming special bonds with them along the way. Patients can expect high-quality care and support from Dr. Gillian Noel and her team at this institution.

Dr. Narayanan Venkatasubramani is a doctor specializing in the evaluation and treatment of digestive diseases in children, with a focus on conditions such as celiac disease, pancreas issues, and Eosinophilic Esophagitis. Located at 4709 Creekstone Drive in Durham, North Carolina, United States, the institution provides high-quality healthcare services. The Patient Rating score is based on responses from the nationally-recognized Press Ganey Patient Satisfaction Survey, with ratings measured on a scale of 1 to 5. Duke Health contracts with most major health insurance carriers, ensuring accessibility to quality care for patients.

Sarah M. Heston, MD is a renowned institution located at 2301 Erwin Road in Durham, North Carolina, United States. Specializing in pediatric transplant infectious diseases, Dr. Heston sees patients who have undergone transplantation or are immunocompromised. She conducts pre-transplant evaluations and provides diagnosis and treatment for infections resulting from immunosuppression. Dr. Heston is dedicated to supporting children through their healing journey post-transplantation. Additionally, Dr. Heston conducts research on the gut microbiome and its role in predicting infections and clinical outcomes after stem cell transplant in children. Her ultimate goal is to develop non-antimicrobial therapies that can alter the gut microbiome to prevent infections in pediatric transplant recipients.